Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)

NCT06004388 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Click Therapeutics, Inc.